Notably, each of these variants is unique to a single patient, and 2 patients were carriers for two variants each: Patient H3168 had stop gain variants in FANCA and PALB2, and had a sister with lung cancer, and another sister with breast cancer. Here, FANCA is linked to lung cancer.